← Back to Clinical Trials
Recruiting NCT07848386

NCT07848386 Patient Priorities Aligned Discrete Decision Making for Older Adults With Multiple Chronic Conditions.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07848386
Status Recruiting
Phase —
Sponsor The University of Texas Health Science Center, Houston
Condition Hernia
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2026-04-30
Primary Completion 2027-10-30

Eligibility & Interventions

Sex All sexes
Min Age 60 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
AI Chatbot

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 80 participants in total. It began in 2026-04-30 with a primary completion date of 2027-10-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of the study is to to evaluate an artificial intelligence (AI) powered large language model (LLM) chatbot -PrioritiesAI -that assists patients in understanding, clarifying, and communicating their health priorities and desired outcomes related to elective hernia surgery.

Eligibility Criteria

Inclusion Criteria: * Capacity to provide informed consent * Ability to communicate effectively by phone in English * Access to a working email address that the participant checks regularly * Scheduled for an upcoming outpatient consultation with one of our partner surgeons to discuss elective hernia surgery (femoral, ventral, inguinal, or umbilical) * No significant cognitive impairment that would interfere with meaningful participation To ensure focus on surgical decisions, participants must fall into one of these categories: 1. Patients scheduled for an upcoming outpatient consultation with one of our partner surgeons specifically to discuss a potential surgical procedure 2. Patients who have undergone a surgical procedure performed one of our partner surgeons after January 1, 2025 3. Participants must meet criteria #1 or #2 above and must not have participated in Phase 1 of the study Exclusion Criteria: * Cognitive impairment sufficient to interfere with meaningful participation in Patient Priorities Care (PPC) discussions * Communication challenges that cannot be reasonably accommodated within the study protocol * Inability to complete patient-reported outcome measures independently or with minimal assistance * Lack of decision-making capacity regarding surgical care

Contact & Investigator

Central Contact

Aanand D Naik, MD

✉ Aanand.Naik@uth.tmc.edu

📞 713-500-9000

Principal Investigator

Aanand D Naik, MD

PRINCIPAL INVESTIGATOR

The University of Texas Health Science Center, Houston

Frequently Asked Questions

Who can join the NCT07848386 clinical trial?

This trial is open to participants of all sexes, aged 60 Years or older, studying Hernia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07848386 currently recruiting?

Yes, NCT07848386 is actively recruiting participants. Contact the research team at Aanand.Naik@uth.tmc.edu for enrollment information.

Where is the NCT07848386 trial being conducted?

This trial is being conducted at Houston, United States.

Who is sponsoring the NCT07848386 clinical trial?

NCT07848386 is sponsored by The University of Texas Health Science Center, Houston. The principal investigator is Aanand D Naik, MD at The University of Texas Health Science Center, Houston. The trial plans to enroll 80 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology